rs111033717
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000155.4(GALT):c.552C>A(p.His184Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H184D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000155.4 missense
Scores
Clinical Significance
Conservation
Publications
- classic galactosemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- galactosemiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| GALT | ENST00000378842.8 | c.552C>A | p.His184Gln | missense_variant | Exon 6 of 11 | 1 | NM_000155.4 | ENSP00000368119.4 | ||
| ENSG00000258728 | ENST00000556278.1 | c.297C>A | p.His99Gln | missense_variant | Exon 3 of 8 | 5 | ENSP00000451792.1 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome  AF:  0.00000752  AC: 11AN: 1461844Hom.:  0  Cov.: 33 AF XY:  0.00000688  AC XY: 5AN XY: 727220 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase    Pathogenic:3Uncertain:1 
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 184 of the GALT protein (p.His184Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with classic galactosemia (PMID: 10535394, 11397328). ClinVar contains an entry for this variant (Variation ID: 25210). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GALT protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: GALT c.552C>A (p.His184Gln) results in a non-conservative amino acid change located in the Galactose-1-phosphate uridyl transferase, N-terminal domain (IPR005849) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant was absent in 251476 control chromosomes. c.552C>A has been reported in the literature in individuals affected with Galactosemia (Palmieri_1999, Yang_2002, Berry_2004, Robertson_2000). These data indicate that the variant is likely to be associated with disease. Three publications report experimental evidence evaluating an impact on protein function, however, none of these studies allows convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 14728988, 20008339, 10529216, 10535394, 11397328, 10408771, 11754113). ClinVar contains an entry for this variant (Variation ID: 25210). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided    Pathogenic:2 
The H184Q variant in the GALT gene has been reported previously in patients with galactosemia (Tyfield et al. 1999; Yang et al. 2002). The H184Q variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The H184Q variant is a semi-conservative amino acid substitution. The H184Q variant occurs at a position within the catalytic site of the galactose 1-phosphate uridyltransferase protein that is conserved across species (Elsas et al. 1998). In silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we interpret H184Q as being likely pathogenic. -
PP3, PP4, PM2, PM3_strong, PS4_moderate -
Galactosemia    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at